House Minority Leader John Boehner today endorsed a one-year freeze on all new regulations, according to Congressional Quarterly. "Having a moratorium on new federal regulations is a great idea,” he said. “It sends a wonderful signal to the private sector that they'll have some breathing room."

A Food and Drug Administration (FDA) advisory panel debated the safety of the diabetes drug Avandia today. In 2007, a study determined that Avandia raises the risk of heart attack in patients taking it. The drug’s safety and effectiveness have been hotly contested ever since.

One year after the White House was supposed to chart a new course for the role of scientists and the integrity of scientific information in government, federal employees and the public continue to await reform.

The Center for Responsive Politics (CRP) released a new report addressing the question of whether federal lobbyists are "deregistering." CRP found that the increase in deregistrations increased before President Barack Obama took office. As it turns out, policies meant to limit lobbyists' influence may not have played as great of a role in deregistrations as originally thought. CRP points out that "the process of deregistering is not straightforward."